The Contraceptive drugs and devices Market size was valued at USD 27.94 Billion in 2023 and is expected to reach USD 44.87 Billion by 2030, at a CAGR of 7.0% from forecast 2024 to 2030Contraceptive drugs and devices Market Overview
The global Contraceptive drugs and devices Market is forecasted to experience substantial growth in the upcoming years, fuelled by increasing awareness of STDs and other diseases and rising government initiatives to promote the product. According to the report, the global Contraceptive drugs and devices Market size was valued at USD 27.94 Billion in 2023 and is forecasted to reach USD 44.87 Billion by 2030, growing at a CAGR of 7.00% from 2024 to 2030. The North America region is projected to witness the highest growth rate during the forecast period. Various other factors that are driving and restraining the market’s growth are discussed below. Some of the elements are the side product's side effects and the cultural barriers that have been analysed thoroughly. The report also discusses various key players involved in the market and their recently implemented strategies. The news about the partnership has also been studied thoroughly.To know about the Research Methodology :- Request Free Sample Report
Contraceptive drugs and devices Market Dynamics
The female segment is a segment which would witness the contraceptive drugs and devices market. A growing number of unwanted pregnancies, rising sexually transmitted illnesses, and greater adoption of contraceptive medications and devices will all likely contribute to the female market segment for contraceptive drugs and devices market expanding significantly throughout the forecast period. The main driver boosting demand for the female contraception market is the increased adoption of contraceptive medications and devices. For instance, a June 2021 publication in the Journal of Family Medicine and Primary Care showed a prevalence rate of 75% for contraception. The most common female contraceptive methods were tubectomy (81.6%), intrauterine devices (6.3%), and oral contraceptive pills (0.7%). As a result, it is projected that increased usage of contraceptive drugs and equipment would spur market growth. Over the forecast period, the market's expansion is projected to be aided by companies putting more emphasis on implementing different business strategies such as product launches, mergers, and company spin-offs. For instance, under an exclusive licence, marketing, and distribution agreement with Slayback Pharma LLC, Lupin, a pharmaceutical firm with headquarters in Mumbai, introduced Merzee capsules in April 2022. The public listings for NEXPLANON (etonogestrel extended-release subdermal implant) in Quebec under the Régie de l'assurance Maladie du Québec (RAMQ) were also announced by Organon in November 2021. Similarly, Sebela Pharmaceuticals Inc. and PRA Health Sciences are working together to undertake a phase III clinical trial in June 2021 to evaluate LevoCept, a long-acting reversible intrauterine system, for its effectiveness, safety, and tolerability as a contraceptive. The rising government initiative drives the contraceptive drugs and devices market Government driver is identified as another driving factor for the contraceptive drugs and devices market. The government have introduced several initiatives which help in the market growth. The government of India have launched PM Jan Dhan Yojna, which provides financial services to people experiencing poverty, including contraception. Kenya’s government provides free condoms to all citizens. The US also has the Affordable Care Act, which covers contraception without deductibles. Religious and cultural restrictions would affect the Contraceptive drugs and devices market There are social or strict forbiddances on utilising contraception in a few districts of the world. These restrictions may vary from community to community and nation to nation. For example, while some religions forbid all contraception, others only forbid a few. In addition, cultural expectations can discourage the use of on, particularly in nations where women are expected to have large families. Regardless of whether an individual needs to take con contraception, these limitations might make it hard to gain admittance to it. As a result, unanticipated pregnancies and other reproductive health issues may occur. Working with strict and local area pioneers to educate them regarding the benefits of contraception and find answers to this issue is essential.Contraceptive drugs and devices Market Regional Insights:
North America was the largest market having a sizable proportion in 2023. This supremacy is a result of several things. First is more knowledge about contraception, encouraging people to utilise contraceptive pills and devices. The area also has a relatively high disposable income, which enables people to buy and access various contraceptive techniques. Additionally, North America gains from a robust healthcare system that makes contraceptives accessible and widely distributed. Last but not least, supportive government policies promote family planning programmes and support them, which contributes to the market's expansion. The second-largest Contraceptive drugs and devices market is closely followed by Europe in 2023. Similar characteristics exist in Europe and North America, which helps explain its market position. Additionally, the area’s population has a high level of awareness regarding contraception. Additionally, the relatively high disposable income levels allow people to buy and select from various contraceptive medications and technologies. Furthermore, Europe has a developed healthcare system that makes contraceptive treatments more widely accessible and available. The third-largest market in terms of Contraceptive drugs and devices market share in 2023 is the Asia-Pacific region, which accounts for around 10% of global sales. This area has a bright future for expansion for several reasons. First off, the population of the site is expanding quickly, increasing the need for contraceptive medications and devices. Additionally, there is a growing awareness of family planning and contraception as societies appreciate the significance of reproductive health. Growing disposable income levels also help the market expand since more people can afford contraceptives. Favourable government initiatives to support family planning and reproductive health also contribute to the market's growth. Latin America was projected to have the fourth-largest Contraceptive drugs and devices market share in 2023. Like other regions, Latin America experiences growth due to a growing population, rising disposable income, and greater public awareness of the need for contraception and family planning. These factors impact the local adoption and utilisation of contraceptive drugs and methods. The Middle East and Africa region is occupy the fifth spot in 2023. Population growth, improved awareness of contraception, and rising disposable income all support market expansion in the area. As local communities learn the benefits of family planning, the demand for contraceptive drugs and supplies steadily grows. The Asia-Pacific area is predicted to grow the fastest during the forecast period. A few factors contributing to this expansion include the region's growing population, more understanding of contraception and family planning, rising disposable income levels that make it more affordable, and pro-reproductive health government initiatives.Contraceptive drugs and devices Market Segment Analysis:
Based on Product Type: The market is segmented into Contraceptive Drugs and Contraceptive Devices. The Contraceptive Drugs segment held the largest Contraceptive drugs and devices Market share in 2023. The Contraceptive Drugs segment is further sub-segmented into Oral Contraceptive Pills, Contraceptive Injectables and Topical Contraceptives. The oral segment has captured the largest market share, propelled by the widespread adoption of oral medications in both developed and developing nations worldwide. This increased demand can be attributed to the significant clinical advantages offered by oral medicines compared to alternative contraceptive methods such as injectables and patches. Additionally, the convenience of administering oral pills, coupled with their growing accessibility in pharmacies, public hospitals, and other outlets, further fuels the adoption rate of this segment throughout the study period.Competitive Landscape:
Prominent corporations such as Bayer AG, Pfizer Inc., Merck & Co., Inc., Teva Pharmaceuticals Ltd, Agile Therapeutics, Inc., Allergan plc, Ani Pharmaceuticals Inc., Church & Dwight Co., Inc., Fuji Latex Co., Ltd, and Johnson & Johnson are competing for a share of the market in contraceptive drugs and devices. These enterprises employ various strategies to gain an edge, including developing new products, marketing and sales initiatives, and competitive pricing. The product development focuses on offering and improving contraceptive medications and technologies, like Bayer AG's recently devised contraceptive pill that boasts enhanced efficacy and fewer adverse effects. Marketing and sales efforts entail considerable investments to promote their goods, with Pfizer Inc. being renowned for its extensive advertising campaigns. Pricing tactics also play a role, as companies like Teva Pharmaceuticals Ltd provide more affordable options to attract budget-conscious consumers. The Contraceptive drugs and devices market's competitive landscape constantly evolves, with new players and established companies expanding their product offerings and market presence, driving further competition and fostering innovation. As the market progresses, ongoing innovation, competition, and policy changes are expected in the future. These advancements will lead to improved contraceptive options and better access to reproductive healthcare.Contraceptive Drugs and Devices Market Scope: Inquire before buying
Global Contraceptive Drugs and Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 27.94 Bn. Forecast Period 2024 to 2030 CAGR: 7% Market Size in 2030: US $ 44.87 Bn. Segments Covered: By Product Type Contraceptive Drugs Oral Contraceptive Pills Contraceptive Injectables Topical Contraceptives Contraceptive Devices Male Contraceptive Devices Female Contraceptive Devices By End User Male Female Contraceptive Drugs and Devices Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) South America (Brazil, Argentina Rest of South America) Middle East & Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)Contraceptive drugs and devices Market Key Players
1. Pfizer Inc. (United States) 2. Merck & Co., Inc. (United States) 3. Teva Pharmaceuticals Ltd (Israel) 4. Agile Therapeutics, Inc. (United States) 5. Allergan plc (Ireland) 6. Ani Pharmaceuticals Inc. (United States) 7. Church & Dwight Co., Inc. (United States) 8. Fuji Latex Co., Ltd (Japan) 9. Johnson & Johnson (United States) 10. Mylan N.V. (United States) 11. Reckitt Benckiser Group plc (United Kingdom) 12. The Female Health Company (United States) 13. Medisafe Distribution Inc. (Canada) 14. Eurovital (France) 15. Lupin Limited (India) 16. HLL Lifecare Limited (India) 17. Mithra Pharmaceuticals (Belgium) 18. Afaxys, Inc. (United States) 19. Okamoto Industries, Inc. (Japan) 20. Mayer Laboratories, Inc. (United States) 21. CooperSurgical, Inc. (United States) 22. The Female Health Company (United States) 23. Biosante Pharmaceuticals, Inc. (United States) 24. Guilin Pharmaceutical Co., Ltd. (China) 25. Cipla Ltd. (India) 26. DKT International (United States)FAQs:
1. What are the growth drivers for the Contraceptive drugs and devices Market? Ans: Government initiative is one of the primary drivers for the contraceptive drugs and devices market. 2. What is the major restraint for the Contraceptive drugs and devices Market growth? Ans: The lack of awareness and cultural barriers are among the restraints of the contraceptive drugs and devices market. 3. Which region leading the global Contraceptive drugs and devices Market during the forecast period? Ans: North America is expected to be leading the Contraceptive drugs and devices Market during the forecast period. 4. What is the projected market size & growth rate of the Contraceptive drugs and devices Market? Ans: The projected market size for the contraceptive drugs and devices market is 44.87 Bn USD with a CAGR of 7.0% 5. What segments are covered in the Contraceptive drugs and devices Market report? Ans: Some segments included in the contraceptive drugs and devices market are the segments by Product Type and End User.
1. Contraceptive drugs and devices Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Contraceptive drugs and devices Market: Dynamics 2.1. Contraceptive drugs and devices Market Trends by Region 2.1.1. North America Contraceptive drugs and devices Market Trends 2.1.2. Europe Contraceptive drugs and devices Market Trends 2.1.3. Asia Pacific Contraceptive drugs and devices Market Trends 2.1.4. Middle East and Africa Contraceptive drugs and devices Market Trends 2.1.5. South America Contraceptive drugs and devices Market Trends 2.2. Contraceptive drugs and devices Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Contraceptive drugs and devices Market Drivers 2.2.1.2. North America Contraceptive drugs and devices Market Restraints 2.2.1.3. North America Contraceptive drugs and devices Market Opportunities 2.2.1.4. North America Contraceptive drugs and devices Market Challenges 2.2.2. Europe 2.2.2.1. Europe Contraceptive drugs and devices Market Drivers 2.2.2.2. Europe Contraceptive drugs and devices Market Restraints 2.2.2.3. Europe Contraceptive drugs and devices Market Opportunities 2.2.2.4. Europe Contraceptive drugs and devices Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Contraceptive drugs and devices Market Drivers 2.2.3.2. Asia Pacific Contraceptive drugs and devices Market Restraints 2.2.3.3. Asia Pacific Contraceptive drugs and devices Market Opportunities 2.2.3.4. Asia Pacific Contraceptive drugs and devices Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Contraceptive drugs and devices Market Drivers 2.2.4.2. Middle East and Africa Contraceptive drugs and devices Market Restraints 2.2.4.3. Middle East and Africa Contraceptive drugs and devices Market Opportunities 2.2.4.4. Middle East and Africa Contraceptive drugs and devices Market Challenges 2.2.5. South America 2.2.5.1. South America Contraceptive drugs and devices Market Drivers 2.2.5.2. South America Contraceptive drugs and devices Market Restraints 2.2.5.3. South America Contraceptive drugs and devices Market Opportunities 2.2.5.4. South America Contraceptive drugs and devices Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Contraceptive drugs and devices Industry 2.8. Analysis of Government Schemes and Initiatives For Contraceptive drugs and devices Industry 2.9. Contraceptive drugs and devices Market Trade Analysis 2.10. The Global Pandemic Impact on Contraceptive drugs and devices Market 3. Contraceptive drugs and devices Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 3.1.1. Contraceptive Drugs 3.1.2. Oral Contraceptive Pills 3.1.3. Contraceptive Injectables 3.1.4. Topical Contraceptives 3.1.5. Contraceptive Devices 3.1.6. Male Contraceptive Devices 3.1.7. Female Contraceptive Devices 3.2. Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 3.2.1. Male 3.2.2. Female 3.3. Contraceptive drugs and devices Market Size and Forecast, by Region (2023-2030) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Contraceptive drugs and devices Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Contraceptive Drugs 4.1.2. Oral Contraceptive Pills 4.1.3. Contraceptive Injectables 4.1.4. Topical Contraceptives 4.1.5. Contraceptive Devices 4.1.6. Male Contraceptive Devices 4.1.7. Female Contraceptive Devices 4.2. North America Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 4.2.1. Male 4.2.2. Female 4.3. North America Contraceptive drugs and devices Market Size and Forecast, by Country (2023-2030) 4.3.1. United States 4.3.1.1. United States Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 4.3.1.1.1. Contraceptive Drugs 4.3.1.1.2. Oral Contraceptive Pills 4.3.1.1.3. Contraceptive Injectables 4.3.1.1.4. Topical Contraceptives 4.3.1.1.5. Contraceptive Devices 4.3.1.1.6. Male Contraceptive Devices 4.3.1.1.7. Female Contraceptive Devices 4.3.1.2. United States Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 4.3.1.2.1. Male 4.3.1.2.2. Female 4.3.2. Canada 4.3.2.1. Canada Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 4.3.2.1.1. Contraceptive Drugs 4.3.2.1.2. Oral Contraceptive Pills 4.3.2.1.3. Contraceptive Injectables 4.3.2.1.4. Topical Contraceptives 4.3.2.1.5. Contraceptive Devices 4.3.2.1.6. Male Contraceptive Devices 4.3.2.1.7. Female Contraceptive Devices 4.3.2.2. Canada Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 4.3.2.2.1. Male 4.3.2.2.2. Female 4.3.3. Mexico 4.3.3.1. Mexico Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 4.3.3.1.1. Contraceptive Drugs 4.3.3.1.2. Oral Contraceptive Pills 4.3.3.1.3. Contraceptive Injectables 4.3.3.1.4. Topical Contraceptives 4.3.3.1.5. Contraceptive Devices 4.3.3.1.6. Male Contraceptive Devices 4.3.3.1.7. Female Contraceptive Devices 4.3.3.2. Mexico Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 4.3.3.2.1. Male 4.3.3.2.2. Female 5. Europe Contraceptive drugs and devices Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.2. Europe Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3. Europe Contraceptive drugs and devices Market Size and Forecast, by Country (2023-2030) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.1.2. United Kingdom Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.2. France 5.3.2.1. France Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.2.2. France Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.3. Germany 5.3.3.1. Germany Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.3.2. Germany Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.4. Italy 5.3.4.1. Italy Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.4.2. Italy Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.5. Spain 5.3.5.1. Spain Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.5.2. Spain Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.6. Sweden 5.3.6.1. Sweden Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.6.2. Sweden Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.7. Austria 5.3.7.1. Austria Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.7.2. Austria Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 5.3.8.2. Rest of Europe Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific Contraceptive drugs and devices Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.2. Asia Pacific Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3. Asia Pacific Contraceptive drugs and devices Market Size and Forecast, by Country (2023-2030) 6.3.1. China 6.3.1.1. China Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.1.2. China Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.2. S Korea 6.3.2.1. S Korea Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.2.2. S Korea Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.3. Japan 6.3.3.1. Japan Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.3.2. Japan Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.4. India 6.3.4.1. India Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.4.2. India Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.5. Australia 6.3.5.1. Australia Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.5.2. Australia Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.6. Indonesia 6.3.6.1. Indonesia Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.6.2. Indonesia Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.7. Malaysia 6.3.7.1. Malaysia Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.7.2. Malaysia Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.8. Vietnam 6.3.8.1. Vietnam Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.8.2. Vietnam Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.9. Taiwan 6.3.9.1. Taiwan Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.9.2. Taiwan Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 6.3.10.2. Rest of Asia Pacific Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa Contraceptive drugs and devices Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 7.2. Middle East and Africa Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 7.3. Middle East and Africa Contraceptive drugs and devices Market Size and Forecast, by Country (2023-2030) 7.3.1. South Africa 7.3.1.1. South Africa Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 7.3.1.2. South Africa Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 7.3.2. GCC 7.3.2.1. GCC Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 7.3.2.2. GCC Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 7.3.3. Nigeria 7.3.3.1. Nigeria Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 7.3.3.2. Nigeria Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 7.3.4.2. Rest of ME&A Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 8. South America Contraceptive drugs and devices Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 8.2. South America Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 8.3. South America Contraceptive drugs and devices Market Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 8.3.1.2. Brazil Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 8.3.2.2. Argentina Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Contraceptive drugs and devices Market Size and Forecast, by Product Type (2023-2030) 8.3.3.2. Rest Of South America Contraceptive drugs and devices Market Size and Forecast, by End User (2023-2030) 9. Global Contraceptive drugs and devices Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Contraceptive drugs and devices Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Pfizer Inc. (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Merck & Co., Inc. (United States) 10.3. Teva Pharmaceuticals Ltd (Israel) 10.4. Agile Therapeutics, Inc. (United States) 10.5. Allergan plc (Ireland) 10.6. Ani Pharmaceuticals Inc. (United States) 10.7. Church & Dwight Co., Inc. (United States) 10.8. Fuji Latex Co., Ltd (Japan) 10.9. Johnson & Johnson (United States) 10.10. Mylan N.V. (United States) 10.11. Reckitt Benckiser Group plc (United Kingdom) 10.12. The Female Health Company (United States) 10.13. Medisafe Distribution Inc. (Canada) 10.14. Eurovital (France) 10.15. Lupin Limited (India) 10.16. HLL Lifecare Limited (India) 10.17. Mithra Pharmaceuticals (Belgium) 10.18. Afaxys, Inc. (United States) 10.19. Okamoto Industries, Inc. (Japan) 10.20. Mayer Laboratories, Inc. (United States) 10.21. CooperSurgical, Inc. (United States) 10.22. The Female Health Company (United States) 10.23. Biosante Pharmaceuticals, Inc. (United States) 10.24. Guilin Pharmaceutical Co., Ltd. (China) 10.25. Cipla Ltd. (India) 10.26. DKT International (United States) 11. Key Findings 12. Industry Recommendations 13. Contraceptive drugs and devices Market: Research Methodology 14. Terms and Glossary